nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—SLCO1B3—Docetaxel—head and neck cancer	0.223	0.28	CbGbCtD
Telmisartan—ABCC2—Vinblastine—head and neck cancer	0.139	0.174	CbGbCtD
Telmisartan—ABCG2—Fluorouracil—head and neck cancer	0.135	0.17	CbGbCtD
Telmisartan—ABCC2—Docetaxel—head and neck cancer	0.114	0.143	CbGbCtD
Telmisartan—ABCG2—Docetaxel—head and neck cancer	0.103	0.13	CbGbCtD
Telmisartan—ABCB1—Vinblastine—head and neck cancer	0.0452	0.0567	CbGbCtD
Telmisartan—ABCB1—Docetaxel—head and neck cancer	0.0373	0.0467	CbGbCtD
Telmisartan—Edema of lower extremities—Docetaxel—head and neck cancer	0.00462	0.0314	CcSEcCtD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.00312	0.0565	CbGpPWpGaD
Telmisartan—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.00287	0.0196	CcSEcCtD
Telmisartan—PPARG—Differentiation of white and brown adipocyte   —CEBPA—head and neck cancer	0.00282	0.051	CbGpPWpGaD
Telmisartan—Enteritis—Docetaxel—head and neck cancer	0.00271	0.0185	CcSEcCtD
Telmisartan—Skin ulcer—Hydroxyurea—head and neck cancer	0.00229	0.0156	CcSEcCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.00213	0.0384	CbGpPWpGaD
Telmisartan—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00192	0.0131	CcSEcCtD
Telmisartan—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00189	0.0128	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00185	0.0334	CbGpPWpGaD
Telmisartan—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00182	0.0124	CcSEcCtD
Telmisartan—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00171	0.031	CbGpPWpGaD
Telmisartan—Foetor hepaticus—Docetaxel—head and neck cancer	0.00163	0.0111	CcSEcCtD
Telmisartan—Haemorrhoids—Docetaxel—head and neck cancer	0.00158	0.0107	CcSEcCtD
Telmisartan—PPARG—Nuclear Receptors—RARB—head and neck cancer	0.00157	0.0284	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00144	0.026	CbGpPWpGaD
Telmisartan—Renal failure acute—Hydroxyurea—head and neck cancer	0.0014	0.00955	CcSEcCtD
Telmisartan—Liver disorder—Docetaxel—head and neck cancer	0.00136	0.00926	CcSEcCtD
Telmisartan—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00135	0.00917	CcSEcCtD
Telmisartan—Interstitial lung disease—Docetaxel—head and neck cancer	0.00131	0.00892	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CEBPA—head and neck cancer	0.0013	0.0234	CbGpPWpGaD
Telmisartan—Face oedema—Hydroxyurea—head and neck cancer	0.00125	0.00851	CcSEcCtD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00124	0.0224	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00123	0.0222	CbGpPWpGaD
Telmisartan—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00121	0.00826	CcSEcCtD
Telmisartan—Angina pectoris—Vinblastine—head and neck cancer	0.0012	0.00814	CcSEcCtD
Telmisartan—Otitis media—Docetaxel—head and neck cancer	0.00119	0.00811	CcSEcCtD
Telmisartan—Breast disorder—Hydroxyurea—head and neck cancer	0.00117	0.00797	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—CEBPA—head and neck cancer	0.00115	0.0207	CbGpPWpGaD
Telmisartan—Rigors—Docetaxel—head and neck cancer	0.00114	0.00773	CcSEcCtD
Telmisartan—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00113	0.0204	CbGpPWpGaD
Telmisartan—Sepsis—Fluorouracil—head and neck cancer	0.00111	0.00759	CcSEcCtD
Telmisartan—Depression—Vinblastine—head and neck cancer	0.00109	0.00743	CcSEcCtD
Telmisartan—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00108	0.00734	CcSEcCtD
Telmisartan—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00107	0.0073	CcSEcCtD
Telmisartan—Myocardial infarction—Vinblastine—head and neck cancer	0.00107	0.0073	CcSEcCtD
Telmisartan—Dysuria—Hydroxyurea—head and neck cancer	0.00105	0.00713	CcSEcCtD
Telmisartan—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00103	0.0186	CbGpPWpGaD
Telmisartan—Bone disorder—Docetaxel—head and neck cancer	0.00103	0.00699	CcSEcCtD
Telmisartan—Infestation—Hydroxyurea—head and neck cancer	0.000998	0.00679	CcSEcCtD
Telmisartan—Infestation NOS—Hydroxyurea—head and neck cancer	0.000998	0.00679	CcSEcCtD
Telmisartan—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000978	0.00666	CcSEcCtD
Telmisartan—Hypoaesthesia—Vinblastine—head and neck cancer	0.000977	0.00665	CcSEcCtD
Telmisartan—Pharyngitis—Vinblastine—head and neck cancer	0.000975	0.00664	CcSEcCtD
Telmisartan—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000944	0.00643	CcSEcCtD
Telmisartan—Osteoarthritis—Fluorouracil—head and neck cancer	0.000932	0.00635	CcSEcCtD
Telmisartan—Hepatocellular injury—Docetaxel—head and neck cancer	0.000927	0.00631	CcSEcCtD
Telmisartan—Blood pressure increased—Docetaxel—head and neck cancer	0.000927	0.00631	CcSEcCtD
Telmisartan—Influenza like illness—Docetaxel—head and neck cancer	0.0009	0.00613	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000874	0.0158	CbGpPWpGaD
Telmisartan—Dry skin—Fluorouracil—head and neck cancer	0.000854	0.00582	CcSEcCtD
Telmisartan—Muscular weakness—Fluorouracil—head and neck cancer	0.000822	0.0056	CcSEcCtD
Telmisartan—Angiopathy—Hydroxyurea—head and neck cancer	0.000813	0.00553	CcSEcCtD
Telmisartan—Sepsis—Docetaxel—head and neck cancer	0.000804	0.00548	CcSEcCtD
Telmisartan—Chills—Hydroxyurea—head and neck cancer	0.000804	0.00547	CcSEcCtD
Telmisartan—Eosinophilia—Fluorouracil—head and neck cancer	0.000798	0.00543	CcSEcCtD
Telmisartan—Ill-defined disorder—Vinblastine—head and neck cancer	0.000793	0.0054	CcSEcCtD
Telmisartan—Anaemia—Vinblastine—head and neck cancer	0.00079	0.00538	CcSEcCtD
Telmisartan—Angina pectoris—Fluorouracil—head and neck cancer	0.000785	0.00534	CcSEcCtD
Telmisartan—Erythema—Hydroxyurea—head and neck cancer	0.00078	0.00531	CcSEcCtD
Telmisartan—Malaise—Vinblastine—head and neck cancer	0.000771	0.00525	CcSEcCtD
Telmisartan—Vertigo—Vinblastine—head and neck cancer	0.000768	0.00523	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—KISS1—head and neck cancer	0.000757	0.0137	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CEBPA—head and neck cancer	0.000754	0.0136	CbGpPWpGaD
Telmisartan—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000749	0.0051	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.000748	0.0135	CbGpPWpGaD
Telmisartan—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000742	0.00505	CcSEcCtD
Telmisartan—Hypertension—Vinblastine—head and neck cancer	0.000738	0.00503	CcSEcCtD
Telmisartan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000724	0.00493	CcSEcCtD
Telmisartan—Pneumonia—Fluorouracil—head and neck cancer	0.000723	0.00492	CcSEcCtD
Telmisartan—Anaemia—Hydroxyurea—head and neck cancer	0.000721	0.00491	CcSEcCtD
Telmisartan—Discomfort—Vinblastine—head and neck cancer	0.000719	0.0049	CcSEcCtD
Telmisartan—Infestation NOS—Fluorouracil—head and neck cancer	0.000718	0.00489	CcSEcCtD
Telmisartan—Infestation—Fluorouracil—head and neck cancer	0.000718	0.00489	CcSEcCtD
Telmisartan—Atrial fibrillation—Docetaxel—head and neck cancer	0.00071	0.00483	CcSEcCtD
Telmisartan—Visual disturbance—Docetaxel—head and neck cancer	0.00071	0.00483	CcSEcCtD
Telmisartan—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000708	0.00482	CcSEcCtD
Telmisartan—Renal impairment—Docetaxel—head and neck cancer	0.000707	0.00481	CcSEcCtD
Telmisartan—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000704	0.00479	CcSEcCtD
Telmisartan—Myocardial infarction—Fluorouracil—head and neck cancer	0.000704	0.00479	CcSEcCtD
Telmisartan—Malaise—Hydroxyurea—head and neck cancer	0.000703	0.00479	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000699	0.0126	CbGpPWpGaD
Telmisartan—Conjunctivitis—Fluorouracil—head and neck cancer	0.000698	0.00475	CcSEcCtD
Telmisartan—Urinary tract infection—Fluorouracil—head and neck cancer	0.000698	0.00475	CcSEcCtD
Telmisartan—Thrombocytopenia—Vinblastine—head and neck cancer	0.000683	0.00465	CcSEcCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.000681	0.0123	CbGpPWpGaD
Telmisartan—Epistaxis—Fluorouracil—head and neck cancer	0.000678	0.00461	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.000677	0.0122	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000676	0.0122	CbGpPWpGaD
Telmisartan—Sinusitis—Fluorouracil—head and neck cancer	0.000674	0.00459	CcSEcCtD
Telmisartan—Pain in extremity—Docetaxel—head and neck cancer	0.000673	0.00458	CcSEcCtD
Telmisartan—Anorexia—Vinblastine—head and neck cancer	0.000665	0.00453	CcSEcCtD
Telmisartan—Migraine—Docetaxel—head and neck cancer	0.000662	0.00451	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000659	0.00449	CcSEcCtD
Telmisartan—Discomfort—Hydroxyurea—head and neck cancer	0.000656	0.00447	CcSEcCtD
Telmisartan—AGTR1—Arf6 trafficking events—CDH1—head and neck cancer	0.000656	0.0119	CbGpPWpGaD
Telmisartan—Rhinitis—Fluorouracil—head and neck cancer	0.000646	0.0044	CcSEcCtD
Telmisartan—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000642	0.00437	CcSEcCtD
Telmisartan—Pharyngitis—Fluorouracil—head and neck cancer	0.00064	0.00436	CcSEcCtD
Telmisartan—Oedema—Hydroxyurea—head and neck cancer	0.000636	0.00433	CcSEcCtD
Telmisartan—Infection—Hydroxyurea—head and neck cancer	0.000632	0.00431	CcSEcCtD
Telmisartan—Paraesthesia—Vinblastine—head and neck cancer	0.000627	0.00427	CcSEcCtD
Telmisartan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000624	0.00425	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—GRP—head and neck cancer	0.000624	0.0113	CbGpPWpGaD
Telmisartan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000623	0.00424	CcSEcCtD
Telmisartan—Skin disorder—Hydroxyurea—head and neck cancer	0.000618	0.00421	CcSEcCtD
Telmisartan—Dry skin—Docetaxel—head and neck cancer	0.000617	0.0042	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—GRP—head and neck cancer	0.000616	0.0111	CbGpPWpGaD
Telmisartan—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000614	0.00418	CcSEcCtD
Telmisartan—PPARG—PPARA activates gene expression—YAP1—head and neck cancer	0.00061	0.011	CbGpPWpGaD
Telmisartan—Breast disorder—Docetaxel—head and neck cancer	0.000608	0.00414	CcSEcCtD
Telmisartan—Anorexia—Hydroxyurea—head and neck cancer	0.000607	0.00413	CcSEcCtD
Telmisartan—Decreased appetite—Vinblastine—head and neck cancer	0.000607	0.00413	CcSEcCtD
Telmisartan—Cramp muscle—Docetaxel—head and neck cancer	0.000606	0.00412	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—STAT6—head and neck cancer	0.000603	0.0109	CbGpPWpGaD
Telmisartan—Constipation—Vinblastine—head and neck cancer	0.000597	0.00406	CcSEcCtD
Telmisartan—Pain—Vinblastine—head and neck cancer	0.000597	0.00406	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.000597	0.0108	CbGpPWpGaD
Telmisartan—Arrhythmia—Fluorouracil—head and neck cancer	0.000576	0.00392	CcSEcCtD
Telmisartan—Feeling abnormal—Vinblastine—head and neck cancer	0.000575	0.00392	CcSEcCtD
Telmisartan—Bronchospasm—Docetaxel—head and neck cancer	0.000572	0.00389	CcSEcCtD
Telmisartan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000571	0.00389	CcSEcCtD
Telmisartan—Dyspnoea—Hydroxyurea—head and neck cancer	0.000567	0.00386	CcSEcCtD
Telmisartan—Angina pectoris—Docetaxel—head and neck cancer	0.000566	0.00386	CcSEcCtD
Telmisartan—Somnolence—Hydroxyurea—head and neck cancer	0.000566	0.00385	CcSEcCtD
Telmisartan—Erythema—Fluorouracil—head and neck cancer	0.000561	0.00382	CcSEcCtD
Telmisartan—Dyspepsia—Hydroxyurea—head and neck cancer	0.00056	0.00381	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000558	0.0101	CbGpPWpGaD
Telmisartan—Decreased appetite—Hydroxyurea—head and neck cancer	0.000553	0.00377	CcSEcCtD
Telmisartan—Abdominal pain—Vinblastine—head and neck cancer	0.000552	0.00376	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00055	0.00374	CcSEcCtD
Telmisartan—Fatigue—Hydroxyurea—head and neck cancer	0.000549	0.00374	CcSEcCtD
Telmisartan—Constipation—Hydroxyurea—head and neck cancer	0.000544	0.00371	CcSEcCtD
Telmisartan—Pain—Hydroxyurea—head and neck cancer	0.000544	0.00371	CcSEcCtD
Telmisartan—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000542	0.0098	CbGpPWpGaD
Telmisartan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000525	0.00357	CcSEcCtD
Telmisartan—Pneumonia—Docetaxel—head and neck cancer	0.000521	0.00355	CcSEcCtD
Telmisartan—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000521	0.00942	CbGpPWpGaD
Telmisartan—Anaemia—Fluorouracil—head and neck cancer	0.000519	0.00353	CcSEcCtD
Telmisartan—Infestation—Docetaxel—head and neck cancer	0.000518	0.00353	CcSEcCtD
Telmisartan—Infestation NOS—Docetaxel—head and neck cancer	0.000518	0.00353	CcSEcCtD
Telmisartan—Hypersensitivity—Vinblastine—head and neck cancer	0.000514	0.0035	CcSEcCtD
Telmisartan—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000511	0.00348	CcSEcCtD
Telmisartan—Renal failure—Docetaxel—head and neck cancer	0.00051	0.00347	CcSEcCtD
Telmisartan—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000508	0.00346	CcSEcCtD
Telmisartan—Myocardial infarction—Docetaxel—head and neck cancer	0.000508	0.00346	CcSEcCtD
Telmisartan—Conjunctivitis—Docetaxel—head and neck cancer	0.000504	0.00343	CcSEcCtD
Telmisartan—Body temperature increased—Hydroxyurea—head and neck cancer	0.000503	0.00343	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000501	0.00906	CbGpPWpGaD
Telmisartan—Asthenia—Vinblastine—head and neck cancer	0.000501	0.00341	CcSEcCtD
Telmisartan—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00049	0.00334	CcSEcCtD
Telmisartan—Epistaxis—Docetaxel—head and neck cancer	0.000489	0.00333	CcSEcCtD
Telmisartan—AGTR1—Arf6 signaling events—EGFR—head and neck cancer	0.000486	0.00878	CbGpPWpGaD
Telmisartan—Myalgia—Fluorouracil—head and neck cancer	0.000478	0.00325	CcSEcCtD
Telmisartan—Chest pain—Fluorouracil—head and neck cancer	0.000478	0.00325	CcSEcCtD
Telmisartan—Diarrhoea—Vinblastine—head and neck cancer	0.000478	0.00325	CcSEcCtD
Telmisartan—Discomfort—Fluorouracil—head and neck cancer	0.000472	0.00321	CcSEcCtD
Telmisartan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000469	0.00319	CcSEcCtD
Telmisartan—Rhinitis—Docetaxel—head and neck cancer	0.000467	0.00318	CcSEcCtD
Telmisartan—Hypoaesthesia—Docetaxel—head and neck cancer	0.000463	0.00315	CcSEcCtD
Telmisartan—Pharyngitis—Docetaxel—head and neck cancer	0.000462	0.00315	CcSEcCtD
Telmisartan—Dizziness—Vinblastine—head and neck cancer	0.000462	0.00314	CcSEcCtD
Telmisartan—Urinary tract disorder—Docetaxel—head and neck cancer	0.00046	0.00313	CcSEcCtD
Telmisartan—Oedema peripheral—Docetaxel—head and neck cancer	0.000459	0.00312	CcSEcCtD
Telmisartan—Oedema—Fluorouracil—head and neck cancer	0.000458	0.00312	CcSEcCtD
Telmisartan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000458	0.00312	CcSEcCtD
Telmisartan—Connective tissue disorder—Docetaxel—head and neck cancer	0.000457	0.00311	CcSEcCtD
Telmisartan—Asthenia—Hydroxyurea—head and neck cancer	0.000457	0.00311	CcSEcCtD
Telmisartan—Urethral disorder—Docetaxel—head and neck cancer	0.000456	0.00311	CcSEcCtD
Telmisartan—Infection—Fluorouracil—head and neck cancer	0.000455	0.0031	CcSEcCtD
Telmisartan—Nervous system disorder—Fluorouracil—head and neck cancer	0.000449	0.00306	CcSEcCtD
Telmisartan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000449	0.00305	CcSEcCtD
Telmisartan—Visual impairment—Docetaxel—head and neck cancer	0.000449	0.00305	CcSEcCtD
Telmisartan—Tachycardia—Fluorouracil—head and neck cancer	0.000447	0.00304	CcSEcCtD
Telmisartan—Vomiting—Vinblastine—head and neck cancer	0.000444	0.00302	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—CASP8—head and neck cancer	0.000438	0.00792	CbGpPWpGaD
Telmisartan—Headache—Vinblastine—head and neck cancer	0.000437	0.00298	CcSEcCtD
Telmisartan—Anorexia—Fluorouracil—head and neck cancer	0.000437	0.00297	CcSEcCtD
Telmisartan—Diarrhoea—Hydroxyurea—head and neck cancer	0.000435	0.00297	CcSEcCtD
Telmisartan—Eye disorder—Docetaxel—head and neck cancer	0.000435	0.00296	CcSEcCtD
Telmisartan—Cardiac disorder—Docetaxel—head and neck cancer	0.000432	0.00294	CcSEcCtD
Telmisartan—Flushing—Docetaxel—head and neck cancer	0.000432	0.00294	CcSEcCtD
Telmisartan—Hypotension—Fluorouracil—head and neck cancer	0.000428	0.00291	CcSEcCtD
Telmisartan—Angiopathy—Docetaxel—head and neck cancer	0.000422	0.00288	CcSEcCtD
Telmisartan—Dizziness—Hydroxyurea—head and neck cancer	0.000421	0.00287	CcSEcCtD
Telmisartan—Immune system disorder—Docetaxel—head and neck cancer	0.00042	0.00286	CcSEcCtD
Telmisartan—Mediastinal disorder—Docetaxel—head and neck cancer	0.000419	0.00286	CcSEcCtD
Telmisartan—Chills—Docetaxel—head and neck cancer	0.000418	0.00284	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000417	0.00284	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—TGFA—head and neck cancer	0.000417	0.00753	CbGpPWpGaD
Telmisartan—Arrhythmia—Docetaxel—head and neck cancer	0.000416	0.00283	CcSEcCtD
Telmisartan—Nausea—Vinblastine—head and neck cancer	0.000415	0.00282	CcSEcCtD
Telmisartan—Insomnia—Fluorouracil—head and neck cancer	0.000414	0.00282	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000413	0.00746	CbGpPWpGaD
Telmisartan—Paraesthesia—Fluorouracil—head and neck cancer	0.000411	0.0028	CcSEcCtD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000411	0.00743	CbGpPWpGaD
Telmisartan—Dyspnoea—Fluorouracil—head and neck cancer	0.000408	0.00278	CcSEcCtD
Telmisartan—Mental disorder—Docetaxel—head and neck cancer	0.000408	0.00278	CcSEcCtD
Telmisartan—Somnolence—Fluorouracil—head and neck cancer	0.000407	0.00277	CcSEcCtD
Telmisartan—Erythema—Docetaxel—head and neck cancer	0.000405	0.00276	CcSEcCtD
Telmisartan—Malnutrition—Docetaxel—head and neck cancer	0.000405	0.00276	CcSEcCtD
Telmisartan—Vomiting—Hydroxyurea—head and neck cancer	0.000405	0.00276	CcSEcCtD
Telmisartan—Dyspepsia—Fluorouracil—head and neck cancer	0.000403	0.00275	CcSEcCtD
Telmisartan—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000403	0.00728	CbGpPWpGaD
Telmisartan—Rash—Hydroxyurea—head and neck cancer	0.000401	0.00273	CcSEcCtD
Telmisartan—Dermatitis—Hydroxyurea—head and neck cancer	0.000401	0.00273	CcSEcCtD
Telmisartan—Headache—Hydroxyurea—head and neck cancer	0.000399	0.00271	CcSEcCtD
Telmisartan—Decreased appetite—Fluorouracil—head and neck cancer	0.000398	0.00271	CcSEcCtD
Telmisartan—Dysgeusia—Docetaxel—head and neck cancer	0.000397	0.0027	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000396	0.00269	CcSEcCtD
Telmisartan—Back pain—Docetaxel—head and neck cancer	0.000392	0.00267	CcSEcCtD
Telmisartan—Pain—Fluorouracil—head and neck cancer	0.000392	0.00267	CcSEcCtD
Telmisartan—Muscle spasms—Docetaxel—head and neck cancer	0.00039	0.00265	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK3—head and neck cancer	0.000384	0.00694	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—head and neck cancer	0.000383	0.00693	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—KISS1—head and neck cancer	0.000382	0.0069	CbGpPWpGaD
Telmisartan—Nausea—Hydroxyurea—head and neck cancer	0.000378	0.00257	CcSEcCtD
Telmisartan—Feeling abnormal—Fluorouracil—head and neck cancer	0.000378	0.00257	CcSEcCtD
Telmisartan—Anaemia—Docetaxel—head and neck cancer	0.000374	0.00255	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—head and neck cancer	0.000365	0.0066	CbGpPWpGaD
Telmisartan—Urticaria—Fluorouracil—head and neck cancer	0.000364	0.00248	CcSEcCtD
Telmisartan—Syncope—Docetaxel—head and neck cancer	0.000363	0.00247	CcSEcCtD
Telmisartan—Body temperature increased—Fluorouracil—head and neck cancer	0.000362	0.00247	CcSEcCtD
Telmisartan—Palpitations—Docetaxel—head and neck cancer	0.000358	0.00244	CcSEcCtD
Telmisartan—Loss of consciousness—Docetaxel—head and neck cancer	0.000356	0.00242	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000355	0.00642	CbGpPWpGaD
Telmisartan—Cough—Docetaxel—head and neck cancer	0.000354	0.00241	CcSEcCtD
Telmisartan—Hypertension—Docetaxel—head and neck cancer	0.00035	0.00238	CcSEcCtD
Telmisartan—Myalgia—Docetaxel—head and neck cancer	0.000345	0.00235	CcSEcCtD
Telmisartan—Chest pain—Docetaxel—head and neck cancer	0.000345	0.00235	CcSEcCtD
Telmisartan—Arthralgia—Docetaxel—head and neck cancer	0.000345	0.00235	CcSEcCtD
Telmisartan—PPARG—PPARA activates gene expression—CYP1A1—head and neck cancer	0.000343	0.0062	CbGpPWpGaD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000343	0.00233	CcSEcCtD
Telmisartan—Hypersensitivity—Fluorouracil—head and neck cancer	0.000338	0.0023	CcSEcCtD
Telmisartan—Dry mouth—Docetaxel—head and neck cancer	0.000337	0.0023	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.000336	0.00607	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—CCND1—head and neck cancer	0.000336	0.00607	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL2—head and neck cancer	0.000331	0.00598	CbGpPWpGaD
Telmisartan—Oedema—Docetaxel—head and neck cancer	0.000331	0.00225	CcSEcCtD
Telmisartan—Anaphylactic shock—Docetaxel—head and neck cancer	0.000331	0.00225	CcSEcCtD
Telmisartan—Infection—Docetaxel—head and neck cancer	0.000329	0.00224	CcSEcCtD
Telmisartan—Shock—Docetaxel—head and neck cancer	0.000325	0.00221	CcSEcCtD
Telmisartan—Nervous system disorder—Docetaxel—head and neck cancer	0.000324	0.00221	CcSEcCtD
Telmisartan—Pruritus—Fluorouracil—head and neck cancer	0.000324	0.00221	CcSEcCtD
Telmisartan—Thrombocytopenia—Docetaxel—head and neck cancer	0.000324	0.0022	CcSEcCtD
Telmisartan—Tachycardia—Docetaxel—head and neck cancer	0.000323	0.0022	CcSEcCtD
Telmisartan—Skin disorder—Docetaxel—head and neck cancer	0.000321	0.00219	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.000317	0.00573	CbGpPWpGaD
Telmisartan—Anorexia—Docetaxel—head and neck cancer	0.000315	0.00215	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—GRP—head and neck cancer	0.000314	0.00568	CbGpPWpGaD
Telmisartan—Diarrhoea—Fluorouracil—head and neck cancer	0.000313	0.00213	CcSEcCtD
Telmisartan—Hypotension—Docetaxel—head and neck cancer	0.000309	0.0021	CcSEcCtD
Telmisartan—Dizziness—Fluorouracil—head and neck cancer	0.000303	0.00206	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000301	0.00205	CcSEcCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—head and neck cancer	0.0003	0.00542	CbGpPWpGaD
Telmisartan—Insomnia—Docetaxel—head and neck cancer	0.000299	0.00204	CcSEcCtD
Telmisartan—Paraesthesia—Docetaxel—head and neck cancer	0.000297	0.00202	CcSEcCtD
Telmisartan—Dyspnoea—Docetaxel—head and neck cancer	0.000295	0.00201	CcSEcCtD
Telmisartan—Somnolence—Docetaxel—head and neck cancer	0.000294	0.002	CcSEcCtD
Telmisartan—Vomiting—Fluorouracil—head and neck cancer	0.000291	0.00198	CcSEcCtD
Telmisartan—Dyspepsia—Docetaxel—head and neck cancer	0.000291	0.00198	CcSEcCtD
Telmisartan—Rash—Fluorouracil—head and neck cancer	0.000289	0.00197	CcSEcCtD
Telmisartan—Dermatitis—Fluorouracil—head and neck cancer	0.000289	0.00196	CcSEcCtD
Telmisartan—Decreased appetite—Docetaxel—head and neck cancer	0.000287	0.00196	CcSEcCtD
Telmisartan—Headache—Fluorouracil—head and neck cancer	0.000287	0.00195	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000285	0.00194	CcSEcCtD
Telmisartan—Fatigue—Docetaxel—head and neck cancer	0.000285	0.00194	CcSEcCtD
Telmisartan—Pain—Docetaxel—head and neck cancer	0.000283	0.00193	CcSEcCtD
Telmisartan—Constipation—Docetaxel—head and neck cancer	0.000283	0.00193	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—head and neck cancer	0.000281	0.00509	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000277	0.00501	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CCND1—head and neck cancer	0.000277	0.00501	CbGpPWpGaD
Telmisartan—Feeling abnormal—Docetaxel—head and neck cancer	0.000272	0.00186	CcSEcCtD
Telmisartan—Nausea—Fluorouracil—head and neck cancer	0.000272	0.00185	CcSEcCtD
Telmisartan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00027	0.00184	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—MAPK1—head and neck cancer	0.000263	0.00476	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000263	0.00475	CbGpPWpGaD
Telmisartan—Abdominal pain—Docetaxel—head and neck cancer	0.000261	0.00178	CcSEcCtD
Telmisartan—Body temperature increased—Docetaxel—head and neck cancer	0.000261	0.00178	CcSEcCtD
Telmisartan—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00026	0.00471	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CEBPA—head and neck cancer	0.000259	0.00468	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.000259	0.00468	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—UROD—head and neck cancer	0.000247	0.00447	CbGpPWpGaD
Telmisartan—Hypersensitivity—Docetaxel—head and neck cancer	0.000244	0.00166	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—GSTM1—head and neck cancer	0.000242	0.00437	CbGpPWpGaD
Telmisartan—Asthenia—Docetaxel—head and neck cancer	0.000237	0.00162	CcSEcCtD
Telmisartan—Pruritus—Docetaxel—head and neck cancer	0.000234	0.00159	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000232	0.00419	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000231	0.00418	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—STAT3—head and neck cancer	0.000228	0.00413	CbGpPWpGaD
Telmisartan—Diarrhoea—Docetaxel—head and neck cancer	0.000226	0.00154	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—TYMS—head and neck cancer	0.000226	0.00409	CbGpPWpGaD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000225	0.00407	CbGpPWpGaD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000222	0.00401	CbGpPWpGaD
Telmisartan—Dizziness—Docetaxel—head and neck cancer	0.000219	0.00149	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—KISS1—head and neck cancer	0.000216	0.0039	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—RARB—head and neck cancer	0.000214	0.00387	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—UROD—head and neck cancer	0.000211	0.00381	CbGpPWpGaD
Telmisartan—Vomiting—Docetaxel—head and neck cancer	0.00021	0.00143	CcSEcCtD
Telmisartan—Rash—Docetaxel—head and neck cancer	0.000208	0.00142	CcSEcCtD
Telmisartan—Dermatitis—Docetaxel—head and neck cancer	0.000208	0.00142	CcSEcCtD
Telmisartan—Headache—Docetaxel—head and neck cancer	0.000207	0.00141	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000207	0.00374	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000204	0.00369	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000198	0.00359	CbGpPWpGaD
Telmisartan—Nausea—Docetaxel—head and neck cancer	0.000196	0.00134	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—KISS1—head and neck cancer	0.000196	0.00354	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000195	0.00352	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000192	0.00347	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—AKT1—head and neck cancer	0.000187	0.00338	CbGpPWpGaD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000182	0.0033	CbGpPWpGaD
Telmisartan—PPARG—SREBP signalling—PIK3CA—head and neck cancer	0.000182	0.0033	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—GRP—head and neck cancer	0.000178	0.00321	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000176	0.00319	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000173	0.00312	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00017	0.00307	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000164	0.00296	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GRP—head and neck cancer	0.000161	0.00292	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000155	0.0028	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000155	0.00279	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—UROD—head and neck cancer	0.000154	0.00278	CbGpPWpGaD
Telmisartan—PPARG—SREBP signalling—AKT1—head and neck cancer	0.000149	0.00269	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—STAT3—head and neck cancer	0.000139	0.00252	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000129	0.00232	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000119	0.00216	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KISS1—head and neck cancer	0.000116	0.00209	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000114	0.00205	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000114	0.00205	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000113	0.00203	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00011	0.00199	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—PTEN—head and neck cancer	0.00011	0.00199	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000109	0.00197	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000108	0.00195	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—RARB—head and neck cancer	0.000103	0.00186	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NAT2—head and neck cancer	0.000103	0.00186	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000102	0.00185	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000101	0.00182	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	9.86e-05	0.00178	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2—head and neck cancer	9.72e-05	0.00176	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	9.69e-05	0.00175	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	9.56e-05	0.00173	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	9.53e-05	0.00172	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GRP—head and neck cancer	9.53e-05	0.00172	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—YAP1—head and neck cancer	9.38e-05	0.0017	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.33e-05	0.00169	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.31e-05	0.00168	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	9.28e-05	0.00168	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT6—head and neck cancer	9.25e-05	0.00167	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.21e-05	0.00167	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	9.13e-05	0.00165	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—DPYD—head and neck cancer	9.01e-05	0.00163	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NOTCH1—head and neck cancer	8.78e-05	0.00159	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NAT2—head and neck cancer	8.76e-05	0.00158	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—YAP1—head and neck cancer	8.55e-05	0.00154	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—UROD—head and neck cancer	8.52e-05	0.00154	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—UROD—head and neck cancer	8.32e-05	0.0015	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NOTCH1—head and neck cancer	8.26e-05	0.00149	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	8.26e-05	0.00149	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—YAP1—head and neck cancer	8.19e-05	0.00148	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—DPYD—head and neck cancer	7.69e-05	0.00139	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—head and neck cancer	7.5e-05	0.00136	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—YAP1—head and neck cancer	7.29e-05	0.00132	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.61e-05	0.0012	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.42e-05	0.00116	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NAT2—head and neck cancer	6.39e-05	0.00116	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.35e-05	0.00115	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	6.08e-05	0.0011	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—DPYD—head and neck cancer	5.6e-05	0.00101	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.6e-05	0.00101	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.48e-05	0.00099	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.45e-05	0.000984	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—YAP1—head and neck cancer	5.32e-05	0.000961	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5.17e-05	0.000935	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TYMS—head and neck cancer	5.13e-05	0.000928	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTM1—head and neck cancer	5.07e-05	0.000917	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GPX1—head and neck cancer	4.86e-05	0.000878	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—head and neck cancer	4.83e-05	0.000874	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1A1—head and neck cancer	4.81e-05	0.000869	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—head and neck cancer	4.79e-05	0.000865	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.78e-05	0.000864	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—head and neck cancer	4.74e-05	0.000856	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.67e-05	0.000845	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK3—head and neck cancer	4.57e-05	0.000826	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.51e-05	0.000815	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TYMS—head and neck cancer	4.38e-05	0.000792	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK1—head and neck cancer	4.35e-05	0.000786	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—head and neck cancer	4.35e-05	0.000786	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—head and neck cancer	4.33e-05	0.000782	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—head and neck cancer	4.3e-05	0.000777	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH1—head and neck cancer	4.23e-05	0.000764	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GPX1—head and neck cancer	4.15e-05	0.000749	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1A1—head and neck cancer	4.1e-05	0.000742	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.07e-05	0.000736	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.95e-05	0.000714	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.85e-05	0.000697	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.76e-05	0.000679	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.72e-05	0.000673	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH1—head and neck cancer	3.69e-05	0.000667	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.67e-05	0.000663	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.67e-05	0.000663	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NAT2—head and neck cancer	3.54e-05	0.00064	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—head and neck cancer	3.49e-05	0.000631	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK3—head and neck cancer	3.46e-05	0.000625	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NAT2—head and neck cancer	3.45e-05	0.000624	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.37e-05	0.000609	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK1—head and neck cancer	3.29e-05	0.000595	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—head and neck cancer	3.29e-05	0.000594	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMS—head and neck cancer	3.19e-05	0.000577	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.18e-05	0.000575	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—head and neck cancer	3.16e-05	0.00057	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—head and neck cancer	3.14e-05	0.000568	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—DPYD—head and neck cancer	3.1e-05	0.000561	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—head and neck cancer	3.08e-05	0.000557	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.08e-05	0.000556	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—DPYD—head and neck cancer	3.03e-05	0.000548	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPX1—head and neck cancer	3.02e-05	0.000546	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—head and neck cancer	2.99e-05	0.000541	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—YAP1—head and neck cancer	2.95e-05	0.000532	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—YAP1—head and neck cancer	2.87e-05	0.00052	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—head and neck cancer	2.86e-05	0.000517	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—head and neck cancer	2.85e-05	0.000516	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—head and neck cancer	2.64e-05	0.000477	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.6e-05	0.00047	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—head and neck cancer	2.57e-05	0.000464	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—head and neck cancer	2.54e-05	0.000459	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—head and neck cancer	2.49e-05	0.000451	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—head and neck cancer	2.48e-05	0.000448	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—head and neck cancer	2.44e-05	0.000441	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—head and neck cancer	2.39e-05	0.000432	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK3—head and neck cancer	2.34e-05	0.000423	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—head and neck cancer	2.33e-05	0.000421	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.21e-05	0.0004	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—head and neck cancer	2.16e-05	0.00039	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—head and neck cancer	2.14e-05	0.000386	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—head and neck cancer	2.13e-05	0.000385	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK3—head and neck cancer	2.04e-05	0.000369	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK1—head and neck cancer	1.94e-05	0.000351	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—head and neck cancer	1.94e-05	0.000351	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.93e-05	0.000349	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—head and neck cancer	1.78e-05	0.000322	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMS—head and neck cancer	1.77e-05	0.00032	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—head and neck cancer	1.76e-05	0.000318	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.75e-05	0.000316	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMS—head and neck cancer	1.73e-05	0.000312	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—head and neck cancer	1.71e-05	0.000308	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—head and neck cancer	1.69e-05	0.000305	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX1—head and neck cancer	1.67e-05	0.000303	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.66e-05	0.0003	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX1—head and neck cancer	1.63e-05	0.000295	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—head and neck cancer	1.63e-05	0.000295	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.62e-05	0.000292	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—head and neck cancer	1.58e-05	0.000285	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—head and neck cancer	1.56e-05	0.000282	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—head and neck cancer	1.55e-05	0.00028	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—head and neck cancer	1.5e-05	0.000271	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—head and neck cancer	1.44e-05	0.00026	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—head and neck cancer	1.38e-05	0.000249	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.36e-05	0.000246	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—head and neck cancer	1.23e-05	0.000222	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.09e-05	0.000198	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—head and neck cancer	9.86e-06	0.000178	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—head and neck cancer	9.62e-06	0.000174	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—head and neck cancer	8.94e-06	0.000162	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—head and neck cancer	8.6e-06	0.000155	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—head and neck cancer	8.39e-06	0.000152	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—head and neck cancer	6.06e-06	0.00011	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.92e-06	0.000107	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—head and neck cancer	4.95e-06	8.95e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—head and neck cancer	4.83e-06	8.74e-05	CbGpPWpGaD
